Centessa Pharmaceuticals plc
CNTADelisted Jun 24, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847903
Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding Centessa Pharmaceuticals plc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 41 | 44 | +3 |
| Shares | 71.8M | 71.8M | −22.6K (0.0%) |
| Value | $350.3M | $288.7M | −$61.6M (−17.6%) |
New holders (6)
Institutions that held Centessa Pharmaceuticals plc at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 242,517 | $975.0K | 0.45% |
| Geode Capital Management, LLC | 13,428 | $53.0K | 0.00% |
| Compagnie Lombard Odier SCmA | 5,820 | $23.0K | 0.00% |
| UBS Group AG | 1,558 | $6.00K | 0.00% |
| China Universal Asset Management Co., Ltd. | 481 | $2.00K | 0.00% |
| Simplex Trading, LLC | 60 | $0 | 0.00% |
Sold out (3)
Institutions that held Centessa Pharmaceuticals plc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Baker Bros. Advisors LP | 1,127,273 | $5.49M |
| Mirae Asset Global Investments Co., Ltd. | 57,342 | $703.0K |
| State of Wyoming | 96 | $0 |